Related Experiment Videos
[Preterm corticosteroid therapy and fetal immobility. Case report].
C Lenoble1, P Kimata, G Carrasset
1Service de gynécologie-obstétrique, hôpital Rothschild, 33, boulevard de Picpus, 75012 Paris, France.
Gynecologie, Obstetrique & Fertilite
|December 14, 2004
Summary
Antenatal corticosteroid therapy for preterm labor can cause fetal immobility. This case highlights challenges in choosing treatment for fetal distress, suggesting Doppler ultrasound may aid therapeutic decisions.
Area of Science:
- Obstetrics and Gynecology
- Fetal Medicine
- Pharmacology
Background:
- Antenatal corticosteroid therapy is standard for women at risk of preterm labor to accelerate fetal lung maturation.
- Known side effects include transient decreases in fetal heart rate variation.
- Fetal immobility is a less commonly reported, but significant, potential adverse effect.
Observation:
- A case of fetal immobility was observed following antenatal corticosteroid administration at 30 weeks gestation.
- The patient presented with acute fetal distress, complicating therapeutic choices.
- Medical supervision was selected as the management strategy.
Findings:
- This case underscores the complexity of managing fetal distress when immobility is present post-corticosteroid therapy.
- The decision-making process for intervention is challenging.
- Literature review suggests additional diagnostic tools may be beneficial.
Implications:
- Further research is needed to understand the mechanisms and incidence of fetal immobility after antenatal corticosteroids.
- Doppler assessment of the umbilical artery may provide valuable information for guiding therapeutic choices in such scenarios.
- Optimizing the risk-benefit balance of antenatal corticosteroids requires careful consideration of potential fetal side effects.